Table II.

Comparison of anti-CMV effects between Group S and Group I.

Anti-CMV effects	Group S	Group I
Incidence rate of CMV pneumonia, %	27.54a	10.34
Average hospital stay, days	22.58±11.33	25.26±9.47
Cure/recovery rate, %	92.11b	100
Mortality rate, %	5.26c	0

^aP<0.05, vs. Group I;

^bP<0.05, vs. Group I;

^cP<0.05, vs. Group I.

CMV, cytomegalovirus; Group S, standard treatment; Group I, improved treatment.